Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study.

Standard

Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study. / Erkapic, Damir; Sperzel, Johannes; Stiller, Sascha; Meltendorf, Ulf; Mermi, Johann; Wegscheider, Karl; Hügl, Burkhard; INSURE Investigators.

In: EUR HEART J, Vol. 34, No. 2, 2, 2013, p. 130-137.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{420e5b27fb09424e82d70f54c93913a9,
title = "Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study.",
abstract = "Prevention of sudden cardiac death by means of the implantable cardioverter/defibrillator (ICD) is considered to be a lifelong therapy. However, it is still unresolved if patients who never experienced an appropriate ICD intervention during generator longevity really need to undergo device replacement.",
keywords = "Humans, Male, Aged, Female, Prospective Studies, Retreatment, Prosthesis Implantation/methods, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Equipment Failure, *Defibrillators, Implantable, Angiotensin Receptor Antagonists/therapeutic use, Arrhythmias, Cardiac/*therapy, Aspirin/therapeutic use, Humans, Male, Aged, Female, Prospective Studies, Retreatment, Prosthesis Implantation/methods, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Equipment Failure, *Defibrillators, Implantable, Angiotensin Receptor Antagonists/therapeutic use, Arrhythmias, Cardiac/*therapy, Aspirin/therapeutic use",
author = "Damir Erkapic and Johannes Sperzel and Sascha Stiller and Ulf Meltendorf and Johann Mermi and Karl Wegscheider and Burkhard H{\"u}gl and {INSURE Investigators}",
year = "2013",
language = "English",
volume = "34",
pages = "130--137",
journal = "EUR HEART J",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study.

AU - Erkapic, Damir

AU - Sperzel, Johannes

AU - Stiller, Sascha

AU - Meltendorf, Ulf

AU - Mermi, Johann

AU - Wegscheider, Karl

AU - Hügl, Burkhard

AU - INSURE Investigators

PY - 2013

Y1 - 2013

N2 - Prevention of sudden cardiac death by means of the implantable cardioverter/defibrillator (ICD) is considered to be a lifelong therapy. However, it is still unresolved if patients who never experienced an appropriate ICD intervention during generator longevity really need to undergo device replacement.

AB - Prevention of sudden cardiac death by means of the implantable cardioverter/defibrillator (ICD) is considered to be a lifelong therapy. However, it is still unresolved if patients who never experienced an appropriate ICD intervention during generator longevity really need to undergo device replacement.

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Prospective Studies

KW - Retreatment

KW - Prosthesis Implantation/methods

KW - Angiotensin-Converting Enzyme Inhibitors/therapeutic use

KW - Equipment Failure

KW - Defibrillators, Implantable

KW - Angiotensin Receptor Antagonists/therapeutic use

KW - Arrhythmias, Cardiac/therapy

KW - Aspirin/therapeutic use

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Prospective Studies

KW - Retreatment

KW - Prosthesis Implantation/methods

KW - Angiotensin-Converting Enzyme Inhibitors/therapeutic use

KW - Equipment Failure

KW - Defibrillators, Implantable

KW - Angiotensin Receptor Antagonists/therapeutic use

KW - Arrhythmias, Cardiac/therapy

KW - Aspirin/therapeutic use

M3 - SCORING: Journal article

VL - 34

SP - 130

EP - 137

JO - EUR HEART J

JF - EUR HEART J

SN - 0195-668X

IS - 2

M1 - 2

ER -